Search

Compugen Ltd

Uždarymo kaina

2.46 2.07

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.33

Max

2.43

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-65M

-7.7M

Pardavimai

-65M

2.2M

P/E

Sektoriaus vid.

6.211

60.549

Pelnas, tenkantis vienai akcijai

-0.08

Pelno marža

-352.436

Darbuotojai

75

EBITDA

-64M

-7.7M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+95.4% upside

Dividendai

By Acuity

Kitas uždarbis

2026-08-05

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-47M

223M

Ankstesnė atidarymo kaina

0.39

Ankstesnė uždarymo kaina

2.46

Compugen Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-07-08 23:56; UTC

Sirius XM Holdings Inc shares are higher in after-market hours, remaining above their 20-day moving average and near the upper end of their one-month trading range.

2026-07-08 23:56; UTC

MercadoLibre Inc. shares declined during after-market hours, reflecting broader market sentiment amid rising oil prices and inflationary pressures from Middle East tensions.

2026-07-08 23:56; UTC

Biogen Inc shares are lower in after-market hours, continuing a trend of four consecutive sessions finishing lower, with no specific news identified for the decline.

2026-07-08 23:52; UTC

UK House Price Balance Declines to -0.33%, Heightening Concerns Over Housing Market Stability Amid Economic Pressures

2026-07-08 23:52; UTC

Positive Shift in U.S. Home Sales Anticipated as June Data Shows 5.9% Year-over-Year Increase Ahead of July Release.

2026-07-08 23:52; UTC

Optimism Grows Ahead of July 9 Release for U.S. Existing Home Sales Amid Lower Mortgage Rates and Increased Listings

2026-07-08 23:52; UTC

Australia's Westpac Consumer Confidence Index shows a 3.5% drop, signaling ongoing economic concerns ahead of July 14 release amid inflationary pressures and market volatility.

2026-07-08 23:52; UTC

Australia's Westpac Consumer Confidence Index set for July 14, 2026 release amid cautious investor sentiment and global economic pressures.

2026-07-08 23:51; UTC

Gilead Sciences shares are lower in after-hours trading, reflecting a decline from earlier levels amid broader market weakness influenced by geopolitical tensions.

2026-07-08 23:51; UTC

News

Broadcom shares rise in after-market hours as analysts project $172 billion in revenue next year, driven by AI infrastructure spending.

2026-07-08 23:51; UTC

U.S. equity markets show mixed results amid rising oil prices and geopolitical tensions, with European markets declining sharply as inflation fears grow.

2026-07-08 23:51; UTC

Geopolitical tensions and rising oil prices drive mixed Asian equity markets, with European indices declining amid inflation concerns and revised global growth forecasts.

2026-07-08 23:51; UTC

Global equity markets decline amid rising oil prices and geopolitical tensions, with U.S. consumer credit unexpectedly falling.

2026-07-08 23:51; UTC

European equity markets drop as DAX 30 falls 2.5% amid escalating Middle East tensions, rising oil prices, and inflation concerns.

2026-07-08 23:51; UTC

Macro News
ETF Constituents
Correlated Moves

Materials Select Sector SPDR Fund declines in after-market hours amid geopolitical tensions affecting global oil markets and related asset sentiment.

2026-07-08 23:51; UTC

News
Social Media

Costco Wholesale reported net sales of $29.24 billion for June but shares declined in after-hours trading amid mixed investor sentiment and broader market trends.

2026-07-08 23:51; UTC

Correlated Moves

The NZD/HKD is higher today, reflecting a modest increase since Tuesday's close, despite declines in European markets, including the DAX 30 Index.

2026-07-08 23:51; UTC

Correlated Moves
Macro News

The New Zealand Dollar has strengthened against major currencies after the Reserve Bank raised its key interest rate to 2.50%.

2026-07-08 23:51; UTC

Macro News
ETF Constituents

iShares MSCI South Korea ETF declines in after-market hours amid KOSPI's significant drop and rising global economic concerns linked to Middle East tensions.

2026-07-08 23:51; UTC

Macro News
ETF Constituents

The iShares U.S. Aerospace & Defense ETF declined in after-market trading amid rising tensions from U.S. military strikes against Iranian targets, impacting key defense firms.

2026-07-08 23:51; UTC

Correlated Moves
Macro News

Bitcoin is trading lower amid rising geopolitical tensions following President Trump's ceasefire announcement with Iran. Earlier, it reached a session high before declining.

2026-07-08 23:46; UTC

Biomarin Pharmaceutical Inc shares are higher in after-market hours, reflecting routine trading activity with minimal fluctuations and positioning above the 20-day moving average.

2026-07-08 23:46; UTC

Fastenal Co shares are trading lower in after-market hours, marking the fifth consecutive day of declines amid broader market weakness linked to geopolitical tensions.

2026-07-08 23:46; UTC

Vertex Pharmaceuticals shares are higher in after-market trading, despite significant declines in European markets amid geopolitical tensions involving the U.S. and Iran.

2026-07-08 23:46; UTC

News
ETF Constituents
Macro News
Correlated Moves

The Financial Select Sector SPDR Fund is higher in after-market trading, supported by strong seasonal patterns and movements in major bank holdings.

2026-07-08 23:46; UTC

Western Digital shares are lower in after-market trading, amid broader market declines linked to geopolitical tensions affecting oil supply routes.

2026-07-08 23:41; UTC

News
Social Media
Correlated Moves

Advanced Micro Devices shares are declining in after-hours trading amid negative sentiment in semiconductor stocks, following the announcement of its upcoming earnings report.

2026-07-08 23:41; UTC

U.S. 30-Year Mortgage Rate Rises to 6.58%, Sparking Decline in Applications Amid Inflation and Economic Uncertainty

2026-07-08 23:41; UTC

Social Media
News

NVIDIA Corp shares declined in after-market trading amid concerns over AI spending and competition. Analysts note cautious investor sentiment contributing to the bearish outlook.

2026-07-08 23:41; UTC

News
Social Media
Correlated Moves

Micron Technology shares traded higher after notable options activity, with $7.2 million in orders for $815 7/17 Puts contributing to a total premium of over $21.5 million.

Akcijų palyginimas

Kainos pokytis

Compugen Ltd Prognozė

Kainos tikslas

By TipRanks

95.4% į viršų

12 mėnesių prognozė

Vidutinis 4.67 USD  95.4%

Aukščiausias 5 USD

Žemiausias 4 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Compugen Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

3

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.
help-icon Live chat